Until now, 37 cases harboring PROKR2 mutations presented pituitary diseases: the majority were CPHD and IGHD, followed by septo-optic dysplasia and pituitary stalk interruption syndrome (Figure 1B). Here, PROKR2 is linked to isolated congenital growth hormone deficiency.